Figure 3 Having demonstrated that metformin treatment alone induces cell death in both HCT116 and SW837 cells, the impact of metformin combined with a clinically-relevant dose of 1.8 Gy radiation was assessed at 48 h post radiation exposure
H., Sgarbanti, R., Panella, S., Nencioni, L., Palamara, A
KPV is not FDA-approved but is potentially moving toward Category 1 compounding eligibility
"We're excited that these data, the first phase 3 data of a next-generation amylin therapy, show promise and we look forward to further investigating Cagrilintide's potential in the dedicated phase 3 RENEW programme," Lange added
Epithalon is being studied for its potential anti-ageing effects, including supporting telomere length and cellular health
It comes in various forms, each with stability and penetration capabilities